Breaking News

NewBiologix Launches with $50M to Advance Novel Technology Platform

Launch includes the completion of a custom built 19,000 sq.-ft. facility designed specifically for cell and gene therapy development.

NewBiologix SA launched as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The launch also includes the completion of a custom built 19,000 square-foot facility designed specifically for cell and gene therapy development. The company’s DNA-based platform is being developed to address key manufacturing challenges associated with the production of recombinant adeno-associat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters